A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Authors

Ralph Salloum
Trent R Hummel
Shiva Senthil Kumar
Kathleen Dorris
Shaoyu Li
Roger J. Packer, George Washington UniversityFollow
+13 additional authors

Document Type

Journal Article

Publication Date

6-27-2016

Journal

Journal of Neuro-oncology

Volume

129

Issue

3

Inclusive Pages

443-451

DOI

10.1007/s11060-016-2189-7

Comments

This is an open access PubMed Central article.

APA Citation

Salloum, R., Hummel, T., Kumar, S., Dorris, K., Li, S., Packer, R. J., & +13 additional authors (2016). A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.. Journal of Neuro-oncology, 129 (3). http://dx.doi.org/10.1007/s11060-016-2189-7

Peer Reviewed

1

Open Access

1